Movano is trading 5.31% lower at $10.03 on October 7, 2026, with no confirmed company-specific catalyst identified.

  • Recent company coverage highlights earlier Corvex developments rather than a new announcement today.
  • Broader markets were weaker, but major-index losses were modest and healthcare was higher. Available evidence does not establish those moves as the direct reason for Movano’s decline; the cause remains unclear.